A rapid method for the purification of wild-type and V804M mutant ret catalytic domain: A tool to study thyroid cancer

International Journal of Biological Macromolecules

Volumn 39, Issue 1-3, 2006, Pages 60-65

  Sala, Elisa ^a,b   Mologni, Luca ^b   Cazzaniga, Sara ^b   Papinutto, Elena ^c   Gambacorti Passerini, Carlo ^b,d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Crystallization; ELISA; IEX and IMAC; Inhibitors screening; RET; Thyroid cancer

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN RET; VANDETANIB;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACULOVIRUS; BINDING SITE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LIGHT SCATTERING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; PURIFICATION; THYROID CARCINOMA; VIRUS EXPRESSION; WILD TYPE;

EID: 33746010224     PISSN: 01418130     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2006.01.006     Document Type: Article

References (33)

1. Traxler P., Bold G., et al. Med. Res. Rev. 21 6 (2001) 499-512
2. Levitzki A. Acc. Chem. Res. 36 6 (2003) 462-469
3. Savage D.G., and Antman K.H. N. Engl. J. Med. 346 9 (2002) 683-693
4. Kantarjian H., Sawyers C., et al. N. Engl. J. Med. 346 9 (2002) 645-652
5. Hayashi H., Ichihara M., et al. Oncogene 19 39 (2000) 4469-4475
6. Jing S., Wen D., et al. Cell 85 7 (1996) 1113-1124
7. Jing S., Yu Y., et al. J. Biol. Chem. 272 52 (1997) 33111-33117
8. Takahashi M. Cytokine Growth Factor Rev. 12 4 (2001) 361-373
9. Manie S., Santoro M., et al. Trends Genet. 17 10 (2001) 580-589
10. Pachnis V., Mankoo B., et al. Development 119 4 (1993) 1005-1017
11. Rossi J., Luukko K., et al. Neuron 22 2 (1999) 243-252
12. Schuchardt A., D'Agati V., et al. Nature 367 6461 (1994) 380-383
13. Schuchardt A., Srinivas S., et al. Oncogene 10 4 (1995) 641-649
14. Tansey M.G., Baloh R.H., et al. Neuron 25 3 (2000) 611-623
15. Tsuzuki T., Takahashi M., et al. Oncogene 10 1 (1995) 191-198
16. Iwashita T., Kurokawa K., et al. Gastroenterology 121 1 (2001) 24-33
17. Romeo G., Ronchetto P., et al. Nature 367 6461 (1994) 377-378
18. Eng C., and Mulligan L.M. Hum. Mutat. 9 2 (1997) 97-109
19. Hofstra R.M., Landsvater R.M., et al. Nature 367 6461 (1994) 375-376
20. Santoro M., Carlomagno F., et al. Science 267 5196 (1995) 381-383
21. Smith D.P., Houghton C., et al. Oncogene 15 10 (1997) 1213-1217
22. Takahashi M., Iwashita T., et al. Hum. Mutat. 13 4 (1999) 331-336
23. Eng C. J. Clin. Oncol. 17 1 (1999) 380-393
24. Jhiang S.M. Oncogene 19 49 (2000) 5590-5597
25. Santoro M., Melillo R.M., et al. Biochimie 81 4 (1999) 397-402
26. Nikiforov Y.E., Rowland J.M., et al. Cancer Res. 57 9 (1997) 1690-1694
27. Takahashi M., Ritz J., et al. Cell 42 2 (1985) 581-588
28. Carlomagno F., Guida T., et al. Oncogene 23 36 (2004) 6056-6063
29. Hanna N.N., McGrath P.C., et al. Curr. Opin. Oncol. 11 1 (1999) 42-47
30. Mologni L., Sala E., et al. Protein Expr. Purif. 41 1 (2005) 177-185
31. Carlomagno F., Vitagliano D., et al. Cancer Res. 62 4 (2002) 1077-1082
32. Carlomagno F., Vitagliano D., et al. J. Clin. Endocrinol. Metab. 88 4 (2003) 1897-1902
33. Gunby R., Tartari C.J., et al. Haematologica 90 7 (2005) 988-990